IPRIPR2019-00451Final Written Decision
Aquestive Therapeutics, Inc. formerly Monosol RX, LLCv.Neurelis, Inc.
IPR challenge of US 9763876.
Type
IPR
Filed
Jan 29, 2019
Instituted
Aug 13, 2019
Decided
—
Patent
Application
14527613
Inventor
Steve Cartt et al
Granted
Sep 19, 2017
01
Timeline
3 milestones
2019-01-29Petition filed
2019-08-13Institution
2020-08-06Terminated
02
Parties & counsel
Petitioner
Aquestive Therapeutics, Inc. formerly Monosol RX, LLC
Counsel
Scola, Danielet al
Patent Owner
Neurelis, Inc.
Counsel
Guise, Jeffreyet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →